ARTHROPLASTY
LIA with ropivacaine and epinephrine lowers 24-hr pain after total hip arthroplasty
Int Orthop. 2016 Nov;40(11):2255-2260150 patients scheduled for total hip arthroplasty were randomized to multimodal analgesia either with or without the use of local infiltration analgesia (LIA). LIA consisted of ropivacaine and epinephrine. Patients were assessed using pain scores, analgesic consumption, perioperative thresholds of mobilization & getting out of bed alone, perioperative blood loss, and postoperative patient-reported outcome at 3 and 12 months. The only significant difference observed between the groups was lower pain over the first 24-hr postoperative period in the LIA group compared to control group. No other significant differences between groups were observed.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
